RNA, U6 small nuclear 544, pseudogene (RNU6-544P)

RNA, U6 small nuclear 544, pseudogene (RNU6-544P) is a genomic locus annotated as a pseudogene of the U6 small nuclear RNA family. U6 snRNA is a core component of the spliceosome, which catalyzes intron removal from pre-mRNA in eukaryotes[1][3]. However, the “544, pseudogene” annotated form lacks coding potential and functional activity; it does not produce functional snRNA or participate in spliceosomal activity. Pseudogenes like RNU6-544P arise from duplication or retrotransposition of parent genes but typically accumulate mutations preventing expression or normal molecular activity[5][4]. Their presence is common in vertebrate genomes and does not imply therapeutic target status or biological function[3][5]. The sequence and structure of RNU6-544P may retain partial similarity to canonical U6 snRNA but cannot substitute its biological role in splicing and gene regulation. Key clarifications: - Pseudogenes are **not considered drug targets** because they do not encode functional protein or RNA; RNU6-544P is such a locus[5][4]. - No known drugs, disease roles, or biomarkers exist for RNU6-544P, nor is it associated with therapeutic challenges. - This entry is marked as **incorrect** for target databases focused on functional, druggable, or mechanistically active molecules: the canonical “U6 small nuclear RNA” functions as part of spliceosomal snRNP, not its pseudogenes[3][1][5]. For most biomedical or pharmacological contexts, only **functional U6 small nuclear RNA (U6 snRNA)** should be annotated, not pseudogene loci such as RNU6-544P.

Other names

RNU6-544PU6 small nuclear RNA pseudogeneU6 RNA pseudogene